LC3B globular structures correlate with survival in esophageal adenocarcinoma

BACKGROUND: Esophageal adenocarcinoma has the fastest growing incidence of any solid tumor in the Western world. Prognosis remains poor with overall five-year survival rates under 25 %. Only a limited number of patients benefit from chemotherapy and there are no biomarkers that can predict outcome....

Descripción completa

Detalles Bibliográficos
Autores principales: El-Mashed, Shereen, O’Donovan, Tracey R., Kay, Elaine W., Abdallah, Ayat R., Cathcart, Mary-Clare, O’Sullivan, Jacintha, O’Grady, Anthony, Reynolds, John, O’Reilly, Seamus, O’Sullivan, Gerald C., McKenna, Sharon L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533787/
https://www.ncbi.nlm.nih.gov/pubmed/26265176
http://dx.doi.org/10.1186/s12885-015-1574-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533787/
https://www.ncbi.nlm.nih.gov/pubmed/26265176
http://dx.doi.org/10.1186/s12885-015-1574-5

Ejemplares similares